GH Research (GHRS) Revenue & Revenue Breakdown
GH Research Revenue Highlights
0
Latest Revenue (Q)
$80.00K
GH Research Revenue by Period
GH Research Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2019-12-31 | - | - |
GH Research generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
GH Research Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-03-31 | $80.00K | 100.00% |
2023-12-31 | - | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | - |
GH Research generated $80.00K in revenue during Q1 2024, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
GH Research Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
RCUS | Arcus Biosciences | $258.00M | $48.00M |
GLUE | Monte Rosa Therapeutics | $75.62M | $4.70M |
STOK | Stoke Therapeutics | $36.55M | $4.89M |
JANX | Janux Therapeutics | $10.59M | $8.90M |
RLAY | Relay Therapeutics | $10.01M | - |
MOLN | Molecular Partners | $7.04M | $2.74M |
HOWL | Werewolf Therapeutics | $1.89M | $1.14M |
MNOV | MediciNova | $1.00M | - |
IKNA | Ikena Oncology | - | - |
ANEB | Anebulo Pharmaceuticals | - | - |
DSGN | Design Therapeutics | - | - |
CGEM | Cullinan Oncology | - | - |
RZLT | Rezolute | - | - |
GPCR | Structure Therapeutics | - | - |
PHVS | Pharvaris | - | - |
GHRS | GH Research | - | $80.00K |
ANNX | Annexon | - | - |
MLYS | Mineralys Therapeutics | - | - |
PEPG | PepGen | - | - |
PMVP | PMV Pharmaceuticals | - | - |
CSBR | Champions Oncology | - | - |